Skip to main content
. 2024 May 31;42(29):3400–3409. doi: 10.1200/JCO.24.00581

FIG A2.

FIG A2.

PFS by investigator assessment in patients without baseline brain metastases. HR, hazard ratio; NR, not reached; PFS, progression-free survival.